Expert Opinion On Drug Delivery

Expert Opinion On Drug Delivery

药物输送专家意见

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Expert Opinion On Drug Delivery》是由Taylor and Francis Ltd.出版社于2004年创办的英文国际期刊(ISSN: 1742-5247,E-ISSN: 1744-7593),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0375...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比16.50%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在103篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Expert Opinion On Drug Delivery审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约103篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 103 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 43 / 354

88%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 84 / 354

76.41%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:11.1 SJR:1.009 SNIP:1.09
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 13 / 183

93%

期刊发文

  • The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)(2) nanoparticles facilitating Cu accumulation in the tumor

    Author: Liu, Hao; Kong, Yihan; Liang, Xue; Liu, Zixu; Guo, Xueting; Yang, Bing; Yin, Tian; He, Haibing; Gou, Jingxin; Zhang, Yu; Tang, Xing

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. 20, Issue 1, pp. 145-158. DOI: 10.1080/17425247.2023.2155631

  • Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs

    Author: Xin, Jinghan; Qin, Mengdi; Ye, Genyang; Gong, Haonan; Li, Mo; Sui, Xiaofan; Liu, Bingyang; Fu, Qiang; He, Zhonggui

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. 20, Issue 1, pp. 1-11. DOI: 10.1080/17425247.2023.2150758

  • Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy

    Author: Wu, Yumin; Feng, Liangzhu

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. 20, Issue 3, pp. 323-333. DOI: 10.1080/17425247.2023.2168640

  • Potential applications of drug delivery technologies against radiation enteritis

    Author: Liu, Dongdong; Wei, Meng; Yan, Wenrui; Xie, Hua; Sun, Yingbao; Yuan, Bochuan; Jin, Yiguang

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. 20, Issue 4, pp. 435-455. DOI: 10.1080/17425247.2023.2183948

  • Biphasic drug release from electrospun structures

    Author: Zhou, Jianfeng; Wang, Pu; Yu, Deng-Guang; Zhu, Yuanjie

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/17425247.2023.2210834

  • Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier

    Author: Bao, Yanning; Lu, Weiyue

    Journal: EXPERT OPINION ON DRUG DELIVERY. 2023; Vol. , Issue , pp. -. DOI: 10.1080/17425247.2023.2193390

  • Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.

    Author: Li Z1, Zhang Y1, Feng N1.

    Journal: Expert Opin Drug Deliv. 2019 Mar;16(3):219-237. doi: 10.1080/17425247.2019.1575806. Epub 2019 Feb 7.

  • An exploration of aptamer internalization mechanisms and their applications in drug delivery.

    Author: Wan LY1,2, Yuan WF2,3, Ai WB4, Ai YW1,2, Wang JJ3, Chu LY5, Zhang YQ2,3, Wu JF1,2,3,4.

    Journal: Expert Opin Drug Deliv. 2019 Mar;16(3):207-218. doi: 10.1080/17425247.2019.1575808. Epub 2019 Feb 6.